These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6724123)

  • 21. Clearance of injected radioactively labelled antibodies to tumour products by liposome-bound second antibodies.
    Keep PA; Searle F; Begent RH; Barratt GM; Boden J; Bagshawe KD; Ryman BE
    Oncodev Biol Med; 1983; 4(4):273-80. PubMed ID: 6601263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unproven methods of cancer treatment.
    CA Cancer J Clin; 1970; 20(1):75-6. PubMed ID: 5005755
    [No Abstract]   [Full Text] [Related]  

  • 23. Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?
    Manson LA
    Immunol Today; 1991 Oct; 12(10):352-5. PubMed ID: 1720318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells.
    Allen TM; Brandeis E; Hansen CB; Kao GY; Zalipsky S
    Biochim Biophys Acta; 1995 Jul; 1237(2):99-108. PubMed ID: 7632714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling the immune responses in patient sera with peptide and cDNA display libraries.
    Sioud M; Hansen M; Dybwad A
    Int J Mol Med; 2000 Aug; 6(2):123-8. PubMed ID: 10891554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The leukocyte adherence inhibition test in diagnostics of malignancies (author's transl)].
    Sarosiek J; Borejszo I
    Przegl Lek; 1981; 38(7):561-5. PubMed ID: 7025111
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune complexes in human malignant tumours. A review.
    Segal-Eiras A; Croce MV
    Allergol Immunopathol (Madr); 1984; 12(3):225-32. PubMed ID: 6382986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer.
    Kamps JA; Koning GA; Velinova MJ; Morselt HW; Wilkens M; Gorter A; Donga J; Scherphof GL
    J Drug Target; 2000; 8(4):235-45. PubMed ID: 11144234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.
    Boks MA; Ambrosini M; Bruijns SC; Kalay H; van Bloois L; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Oct; 216():37-46. PubMed ID: 26151293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies.
    Epenetos AA; Nimmon CC; Arklie J; Elliott AT; Hawkins LA; Knowles RW; Britton KE; Bodmer WF
    Br J Cancer; 1982 Jul; 46(1):1-8. PubMed ID: 7104190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
    Schwartz-Albiez R; Laban S; Eichmüller S; Kirschfink M
    Autoimmun Rev; 2008 Jun; 7(6):491-5. PubMed ID: 18558368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection.
    Sharkey RM; Primus FJ; Goldenberg DM
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2843-6. PubMed ID: 6371822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical promise of tumour immunology.
    Scott AM; Cebon J
    Lancet; 1997 May; 349 Suppl 2():SII19-22. PubMed ID: 9164443
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of serum antibodies induced in syngeneic rats after administration of monoclonal antibody MT10:21.
    North SM; Gurin JL
    Immunology; 1989 Jan; 66(1):26-31. PubMed ID: 15493258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations to the killing of tumours using radiolabelled antibodies.
    Vaughan AT; Anderson P; Dykes PW; Chapman CE; Bradwell AR
    Br J Radiol; 1987 Jun; 60(714):567-72. PubMed ID: 3620814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant chimeric monoclonal antibodies.
    Morrison SL; Schlom J
    Important Adv Oncol; 1990; ():3-18. PubMed ID: 2182522
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumour and cellular localization by use of monoclonal and polyclonal antibodies to placental alkaline phosphatase.
    Jeppsson A; Wahren B; Millán JL; Stigbrand T
    Br J Cancer; 1984 Feb; 49(2):123-8. PubMed ID: 6365130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EpCAM-targeted liposomal si-RNA delivery for treatment of epithelial cancer.
    Bhavsar D; Subramanian K; Sethuraman S; Krishnan UM
    Drug Deliv; 2016 May; 23(4):1101-14. PubMed ID: 25417832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bi-specific antibodies in cancer therapy.
    Wang H; Liu Y; Wei L; Guo Y
    Adv Exp Med Biol; 2000; 465():369-80. PubMed ID: 10810641
    [No Abstract]   [Full Text] [Related]  

  • 40. The site of binding of anti-CEA antibodies to tumour CEA in vivo: an immunocytochemical and autoradiographic approach.
    Moshakis V; Ormerod MG; Westwood JH; Imrie S; Neville AM
    Br J Cancer; 1982 Jul; 46(1):18-21. PubMed ID: 7104194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.